University of Texas MD Anderson Cancer Center

1200px-MD_Anderson_Cancer_Center_logo5rt

The University of Texas MD Anderson Cancer Center (colloquially MD Anderson Cancer Center) is a comprehensive cancer center in Houston, Texas

Using whole blood exchange to help with Alzheimer’s disease?

Could PUL-042, an inhaled therapeutic, be directed against all existing and future variants of the COVID-19 virus as well as future pandemics?

COVID-19 Nasal Vaccine Candidate Effective at Preventing Disease Transmission

Could a polymer wafer placed under the tongue deliver vaccines?

Can activation of a distinct genetic pathway slow the progress of metastatic breast cancer?

‘Quadrapeutics’ works in preclinical study of hard-to-treat tumors

The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells — often by blowing them apart — without harming surrounding normal organs. The research, which is available online this week Nature Medicine, reports that Rice’s “quadrapeutics” technology

‘Quadrapeutics’ works in preclinical study of hard-to-treat tumors

OHSU researchers develop new drug approach that could lead to cures for wide range of diseases

A team led by a longtime Oregon Health & Science University researcher has demonstrated in mice what could be a revolutionary new technique to cure a wide range of human diseases — from cystic fibrosis to cataracts to Alzheimer’s disease — that are caused by “misfolded” protein molecules. Misfolded protein molecules, caused by gene mutation,

OHSU researchers develop new drug approach that could lead to cures for wide range of diseases

New Screening Strategy May Catch Ovarian Cancer at Early Stages

A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of

New Screening Strategy May Catch Ovarian Cancer at Early Stages

‘Nanobubbles’ Plus Chemotherapy Equals Single-Cell Cancer Targeting

Up to 30 times more deadly to cancer cells Using light-harvesting nanoparticles to convert laser energy into “plasmonic nanobubbles,” researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells. In tests on drug-resistant

‘Nanobubbles’ Plus Chemotherapy Equals Single-Cell Cancer Targeting

‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells

High-density lipoprotein’s hauls excess cholesterol to the liver for disposal, but new research suggests “good cholesterol” can also act as a special delivery vehicle of destruction for cancer. Synthetic HDL nanoparticles loaded with small interfering RNA to silence cancer-promoting genes selectively shrunk or destroyed ovarian cancer tumors in mice, a research team led by scientists

‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells

The Latest Bing News on:

University of Texas MD Anderson Cancer Center Research

Targeted therapy achieves responses across multiple cancer types with FGFR alterations
Three clinical trials led by researchers at The University of Texas MD Anderson Cancer Center demonstrated positive results from the targeted therapy erdafitinib for patients with multiple tumor types ...
ZUMA-7 Findings Show Earlier Is Better for Axi-Cel Use in R/R LBCL, Says Dr Jason Westin
Jason Westin, MD, MS, FACP, director of the Lymphoma Clinical Research Program at the University of Texas MD Anderson Cancer Center, gave insight the ZUMA-7 trial of axicabtagene ciloleucel (axi-cel) ...
American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, ...
University of Texas MD Anderson Cancer Center
The U.S. News Doctor Finder has compiled extensive information in each doctor's profile, including where he or she was educated and trained, which hospital he or she admits patients to, and in ...
University of Texas MD Anderson Cancer Center
Lee Moffitt Cancer Center and Research Institute. He has been in practice between 10–20 years. Dr. Hussein Abbas is an oncologist in Houston, TX, and is affiliated with multiple hospitals ...

The Latest Bing News on:

University of Texas MD Anderson Cancer Center Discovery

American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, ...
University of Texas MD Anderson Cancer Center
The U.S. News Doctor Finder has compiled extensive information in each doctor's profile, including where he or she was educated and trained, which hospital he or she admits patients to, and in ...
University of Texas MD Anderson Cancer Center
Higher numbers suggest better survival odds, fewer complications and more patients treated. Survival 30 days after being admitted relative to other hospitals treating similarly complex conditions ...
Pan-cancer T cell atlas reveals new details of tumor microenvironment
A new study led by researchers at The University of Texas MD Anderson Cancer Center, published today ... future T cell studies and biomarker discovery." "The fact that these T STR cells are ...
MD Anderson Cancer Center gets $5.7M for leukemia research
University of Texas MD Anderson Cancer Center in Houston received $5.7 million in funding from the Break Through Cancer foundation to support in-depth research into eradicating an aggressive type ...